Weight Loss with Primary Hyperaldosteronism (Conn's Syndrome) in South Africa

Primary hyperaldosteronism (PHA), also called Conn's syndrome, is a condition in which one or both adrenal glands produce excess aldosterone independently of the renin-angiotensin system. Aldosterone is a hormone that tells the kidneys to retain sodium and excrete potassium; in excess, it causes hypertension that is often resistant to multiple blood pressure medications, potassium depletion (hypokalaemia), fluid retention, and metabolic changes that make weight management frustratingly difficult. PHA is now recognised as the most common endocrine cause of secondary hypertension, affecting approximately 5-10% of all hypertensive patients — yet it remains dramatically underdiagnosed in South Africa. Always work with an endocrinologist for diagnosis and management.

Why PHA Is Underdiagnosed in South Africa

The classic presentation of PHA — severe hypertension plus very low potassium (hypokalaemia) — is actually found in only about 30-40% of cases. The majority of PHA patients have normal or borderline-low potassium, leading clinicians to dismiss the diagnosis. Meanwhile, the patient remains on two, three, or four antihypertensive medications with inadequate BP control, accumulating cardiovascular and metabolic damage.

In SA's public health system, the aldosterone-renin ratio (ARR) — the key screening test for PHA — is available at academic hospital endocrinology units but not routinely checked in primary care hypertension clinics. If you have:

Blood pressure requiring three or more medications to control
Hypertension diagnosed before age 40
Low-normal or below-normal potassium (below 3.5 mmol/L)
Spontaneous muscle cramps, weakness, or excessive urination
Adrenal incidentaloma found on abdominal imaging

...then PHA screening with the ARR is warranted. Ask your doctor or request a referral to endocrinology.

How PHA Causes Weight Problems

Fluid Retention and Oedema

Excess aldosterone drives sodium retention in the kidneys. Sodium draws water with it, expanding extracellular fluid volume. This presents as:

Ankle and lower leg puffiness
Morning facial puffiness
Higher scale weight despite not eating more
Tight shoes, rings, and waistbands

This fluid weight — not fat — can be 2-5 kg or more in significant PHA. It responds rapidly to appropriate treatment but can be mistaken for true fat gain and cause unnecessary distress.

Hypokalaemia and Metabolic Effects

Potassium depletion impairs insulin secretion from pancreatic beta cells. Low potassium directly causes glucose intolerance and increases risk of type 2 diabetes independently of weight. PHA patients frequently have worse glycaemic control than expected from their BMI alone, and may even be diagnosed with type 2 diabetes that improves significantly when PHA is treated.

Aldosterone and Visceral Fat

Emerging research shows that aldosterone acts directly on adipose tissue, promoting visceral fat accumulation and adipocyte dysfunction. PHA patients have higher rates of visceral obesity, metabolic syndrome, and insulin resistance compared to patients with essential hypertension matched for BMI. This is partly reversed by effective PHA treatment.

Fatigue and Activity Limitation

Hypokalaemia causes muscle weakness, cramps, and fatigue — reducing the capacity for physical activity. Resistant hypertension makes exercise feel harder and may cause symptoms (headaches, visual disturbance). Both limit the physical activity needed for weight management.

Treatment Options and Their Nutritional Implications

Surgical (Adrenalectomy) — For Unilateral Adenoma

If CT adrenal imaging and adrenal vein sampling confirm a single aldosterone-producing adenoma, laparoscopic adrenalectomy is curative or near-curative. After surgery:

Blood pressure often improves dramatically; antihypertensive medications are reduced or stopped — monitor for hypotension (dizziness on standing, especially initially)
Potassium normalises; potassium supplements and spironolactone stopped
Fluid retention resolves; expect 2-5 kg weight drop in the weeks post-surgery from fluid loss
Metabolic and insulin sensitivity improvements occur over 3-6 months; take advantage of this window to establish healthy eating and exercise habits

Medical Management — Spironolactone or Eplerenone

For bilateral adrenal hyperplasia (BAH), or patients not suitable for surgery, mineralocorticoid receptor antagonists (spironolactone/Aldactone or eplerenone) block aldosterone's effects at the kidney receptor.

Spironolactone and potassium: Spironolactone is potassium-sparing — it PREVENTS potassium excretion. Do NOT take additional potassium supplements without your doctor's instruction while on spironolactone. Do NOT eat large amounts of high-potassium foods beyond a normal balanced diet without monitoring, as potassium can rise dangerously (hyperkalaemia). Have regular potassium blood tests.

NSAIDs and Spironolactone

Ibuprofen and other NSAIDs (common for pain in SA) reduce the effectiveness of spironolactone and raise the risk of hyperkalaemia when combined. Discuss analgesic options with your doctor — paracetamol (acetaminophen) is generally safer for pain relief on spironolactone.

The Low-Sodium Diet: Your Most Powerful Tool

A strict low-sodium diet is the single most important nutritional intervention in PHA. Excess dietary sodium amplifies the effect of high aldosterone — every extra gram of sodium consumed results in additional fluid retention and blood pressure elevation. Conversely, a low-sodium diet potentiates the effect of spironolactone, often allowing a lower dose with fewer side effects.

Sodium Targets

Ideal for PHA: under 1500mg sodium per day (approximately 3.75g salt — less than one teaspoon)
WHO general recommendation: under 2000mg/day (5g salt)
Current average South African sodium intake: estimated 6-10g salt/day — well above safe limits

Hidden Sodium in the SA Diet: Where It Hides

Food/Product	Approximate Sodium per Serving	PHA Action
Commercial biltong (60g serving)	600-900mg	Limit to very occasional; choose plain lean cuts
Packet soup (1 sachet)	900-1400mg	Avoid; make homemade stock instead
Tinned pilchards in brine	400-600mg per tin	Choose "in tomato sauce" or drain and rinse brine varieties
Cheddar cheese (30g)	200mg	Moderate amounts; choose lower-sodium varieties
Bread (2 slices)	300-500mg	Choose lower-sodium breads; read labels
Soy sauce (1 tsp)	900mg	Avoid; use lemon juice, vinegar, herbs instead
Fast food burger	1000-1800mg	Avoid; one meal = entire day's sodium target
Stock cubes (1 cube)	800-1200mg	Use homemade stock or half a cube in large batches
Droewors/viennas/processed sausage	500-900mg per 100g	Avoid on regular basis
Chakalaka (commercial tinned)	400-700mg per serving	Make fresh at home; no salt added

SA-Friendly Low-Sodium Flavouring

Fresh herbs — parsley, coriander (dhania), thyme, oregano
Garlic and ginger — abundant and cheap; full flavour without sodium
Lemon juice and vinegar — enhance perceived saltiness without sodium
Turmeric, cumin, coriander, paprika, chilli — spice-based flavour is inherently low in sodium
Rooibos-based marinades — strong rooibos tea as a marinade base for chicken or fish adds depth without salt
LoSalt or Nu-Salt — potassium chloride salt substitutes; but AVOID these on spironolactone as they raise potassium

Potassium Management: A Balancing Act

Before treatment, PHA patients often need potassium replenishment — low potassium (hypokalaemia) causes muscle cramps, weakness, constipation, and arrhythmia risk. Once on spironolactone or after adrenalectomy, potassium normalises and supplementation becomes unnecessary or even dangerous.

High-Potassium Foods Useful Pre-Treatment or for BAH Patients on Lower Spironolactone Doses

Banana (422mg per medium banana)
Avocado (487mg per half)
Sweet potato (694mg per medium)
Orange (237mg per medium)
Spinach cooked (839mg per cup)
Tomato paste (664mg per 100g)
Lentils (731mg per cup cooked)

Monitor, do not guess: Potassium management in PHA changes as treatment begins and adjusts. The same high-potassium diet that was appropriate before spironolactone may cause dangerous hyperkalaemia once well-controlled. Regular blood potassium checks — at least monthly when adjusting treatment — are essential.

Weight Loss Strategy in PHA

Step 1: Treat the PHA First

Attempting aggressive weight loss before PHA is adequately controlled is inefficient. The fluid retention, metabolic dysfunction, and fatigue that PHA causes will work against any dietary effort. Get the aldosterone-renin ratio checked, get the diagnosis confirmed, and start treatment. Weight loss becomes substantially easier once PHA is controlled.

Step 2: Strict Low-Sodium Eating as the Foundation

A low-sodium diet treats PHA AND supports weight loss simultaneously — it reduces fluid retention, potentiates medication, and forces avoidance of processed foods that are also high in refined carbohydrates and calories. This is the highest-leverage single dietary change.

Step 3: Anti-Hypertensive Eating Pattern

The DASH diet (Dietary Approaches to Stop Hypertension) is the best-validated eating pattern for PHA-associated hypertension:

Low sodium (as above)
High in potassium-rich fruits and vegetables (banana, avocado, spinach, sweet potato)
High in calcium-rich foods (low-fat dairy, fortified plant alternatives)
High in magnesium (whole grains, legumes, nuts, seeds)
Low in saturated fat
Low in added sugar

Step 4: Exercise When Potassium and BP Are Controlled

Exercise with uncontrolled hypertension or severe hypokalaemia is dangerous. Once BP is below 160/100 and potassium is above 3.5 mmol/L, begin with:

Walking: 150 minutes per week minimum
Swimming: excellent for hypertensive patients — water pressure assists venous return, reduces cardiac load
Resistance/strength training: builds lean mass, improves insulin sensitivity, reduces cardiovascular risk — add after 4-6 weeks of cardiovascular exercise at manageable intensity
Monitor BP response to exercise at initiation; stop and rest if headache, visual changes, or chest discomfort occur

Realistic Weight Loss Expectations in PHA

Treatment Phase	Expected Weight Change	What This Represents
First 2-4 weeks on spironolactone or post-adrenalectomy	2-5 kg loss, sometimes more	Fluid/sodium loss — not fat loss
1-3 months post-treatment start	Stabilisation; slow true fat loss begins	Metabolic function improving; insulin sensitivity recovering
3-12 months on low-sodium diet + exercise	0.5-1 kg/month sustainable fat loss	True body composition improvement; visceral fat reduction
12 months post-adrenalectomy (if curative)	Often 5-10 kg total reduction from pre-diagnosis weight	Combination of fluid, visceral fat, and metabolic normalisation

South African Resources

Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) — specialist directory for endocrinologists; PHA is diagnosed and managed primarily by endocrinology in SA
Academic hospital endocrinology units — Groote Schuur (UCT/GSH), Steve Biko Academic Hospital (SBAHS/UP), Charlotte Maxeke (Wits), Inkosi Albert Luthuli (UKZN) all perform adrenal vein sampling and manage PHA
ADSA — adsa.org.za — find a registered dietitian experienced in hypertension and endocrine conditions; DASH diet guidance is their standard scope
Heart and Stroke Foundation South Africa — heartfoundation.co.za — low-sodium eating resources in the SA context

Primary hyperaldosteronism is underdiagnosed but highly treatable. Getting the right diagnosis and treatment is the single biggest step toward controlling your blood pressure and achieving a healthy weight.

Explore more condition-specific weight management guides on WeightLossDiets.co.za

Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Primary hyperaldosteronism requires diagnosis and management by a qualified endocrinologist. Do not adjust antihypertensive medication, potassium supplements, or spironolactone dosing without medical supervision. Potassium levels can change rapidly with treatment — regular blood monitoring is essential.

Sources: Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA); Endocrine Society Clinical Practice Guidelines for Primary Aldosteronism; Heart and Stroke Foundation South Africa; ADSA; Dietary Guidelines for South Africans; DASH dietary pattern literature (NEJM 1997 Appel et al.; hypertension guidelines update 2023).